Cuivrin

Cuivrin (Trientine Dihydrochloride) is an oral medication used to manage copper toxicity. This prescription drug helps reduce copper levels in the body, often used in conditions like Wilson's disease.

Cuivrin is primarily used to treat copper poisoning by binding excess copper in the body, facilitating its removal. It is often prescribed for conditions like Wilson's disease, where copper accumulation can cause serious health issues. The medication works by chelating copper, which helps to lower copper levels in the blood and tissues.

Common effects of Cuivrin may include gastrointestinal discomfort, such as nausea or vomiting. Some users might experience dizziness or headaches. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Cuivrin should be handled with care, especially by individuals with known allergies to Trientine Dihydrochloride. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring of copper levels may be necessary during treatment.

Cuivrin may interact with certain medications, including iron supplements and other chelating agents. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may exacerbate side effects.